Analysis of features of recurrence after radical nephrectomy in patients with N0M0 renal cell carcinoma

被引:2
作者
Onishi T. [1 ]
Oishi Y. [1 ]
Yamazaki H. [1 ]
Furuta N. [1 ]
Asano K. [1 ]
机构
[1] Department of Urology, Aoto University Hospital, Jikei University School of Medicine, Katsushika-ku, Tokyo 125-8506
关键词
Recurrence; Renal cell carcinoma; Surveillance protocol;
D O I
10.1007/PL00012053
中图分类号
学科分类号
摘要
Background. To reduce unnecessary tests for patients with renal cell carcinoma (RCC) at low risk of metastasis, we designed a postoperative surveillance protocol for N0M0 RCC, based on the features of recurrence. Methods. Of 462 N0M0 RCC patients who underwent radical nephrectomy, 180 patients (39%) showed recurrence. We stratified these patients according to pathological T-stage (pT-stage) with consideration given to the pathological grade of malignancy (grade). A surveillance protocol was designed based on calculated disease-free survival rates. Results. The median time until recurrence was 36 months (range, 1 to 228 months), and 78.3% of all patients, recurrence was diagnosed within 5 years. The rate of recurrence increased in accordance with increased pT-stage: pT1a, 9.9% (10/101); pT1b, 29.8% (39/131); pT2, 41.7% (20/48); pT3a, 58.8% (60/102); pT3b, 60.9% (42/69); pT3c, 71.4% (5/7); pT4, 100% (4/4). Significant differences in disease-free survival rates were observed among the patients at all pT-stages, except for pT1b vs pT2, pT2 vs pT3a, pT3a vs pT3b, and pT3c vs pT4. Basically, a 5-year follow-up was conducted, except for the patients with pT1b (grade 1 + 2), pT2 (grade 1 + 2), pT3a (grade 1, 3), and pT3b (grade 1 + 2), who showed recurrence more than 5 years postoperatively. Conclusion. We conclude that our surveillance protocol for N0M0 RCC after nephrectomy, based on pT-stage and grade, is to some extent a reasonable guideline. However, a further survey of prognostic factors for RCC is necessary, because of the difficulty in predicting recurrence in patients with a low pT-stage and because of the presence of patients with late recurrence.
引用
收藏
页码:297 / 302
页数:5
相关论文
共 14 条
  • [1] Onishi T., Machida T., Masuda F., Et al., Nephrectomy in renal carcinoma with distant metastasis, Br J Urol, 63, pp. 600-604, (1989)
  • [2] Frank W., Stuhldreher D., Saffrin R., Et al., Stage IV renal cell carcinoma, J Urol, 152, pp. 1998-1999, (1994)
  • [3] McNichols D.W., Segura J.W., DeWeerd J., Renal cell carcinoma: Long-term survival and late recurrence, J Urol, 125, pp. 17-23, (1981)
  • [4] Sella A., Swanson D.A., Ro J.Y., Et al., Surgery following response to interferon-α-based therapy for residual renal cell carcinoma, J Urol, 149, pp. 19-22, (1993)
  • [5] Tanguay S., Swanson D.A., Putnam J.B., Renal cell carcinoma metastatic to the lung: Potential benefit in the combination of biological therapy and surgery, J Urol, 156, pp. 1586-1589, (1996)
  • [6] Onishi T., Machida T., Masuda F., Et al., Clinical study of patients with renal cell carcinoma living for more than 10 years after nephrectomy, Br J Urol, 70, pp. 483-487, (1992)
  • [7] Guinan P., Sobin L.H., Algaba F., Et al., TNM staging of renal cell carcinoma, Cancer, 80, pp. 992-993, (1997)
  • [8] Medeiros L.J., Jones E.C., Aizawa S., Et al., Grading of renal cell carcinoma, Cancer, 80, pp. 990-991, (1997)
  • [9] Pagano S., Franzoso F., Ruggeri P., Renal cell carcinoma metastases, Scand J Urol, 30, pp. 165-172, (1996)
  • [10] Siminovitch J.P., Montie J.E., Straffon R.A., Lymphadenectomy in renal cell carcinoma, J Urol, 127, pp. 1090-1091, (1982)